139 related articles for article (PubMed ID: 11887161)
1. Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients.
Jannot MF; Raccah D; De La Tour DD; Coste T; Vague P
Metabolism; 2002 Mar; 51(3):284-91. PubMed ID: 11887161
[TBL] [Abstract][Full Text] [Related]
2. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
Vague P; Dufayet D; Coste T; Moriscot C; Jannot MF; Raccah D
Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
[TBL] [Abstract][Full Text] [Related]
3. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
Vague P; Dufayet D; Lamotte MF; Mouchot C; Raccah D
Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level.
De La Tour DD; Raccah D; Jannot MF; Coste T; Rougerie C; Vague P
Diabetologia; 1998 Sep; 41(9):1080-4. PubMed ID: 9754827
[TBL] [Abstract][Full Text] [Related]
5. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
Raccah D; Gallice P; Pouget J; Vague P
Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
[TBL] [Abstract][Full Text] [Related]
6. C-peptide, Na+,K(+)-ATPase, and diabetes.
Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
[TBL] [Abstract][Full Text] [Related]
7. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
[TBL] [Abstract][Full Text] [Related]
8. Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
Raccah D; Dadoun F; Coste T; Vague P
Horm Metab Res; 1996 Mar; 28(3):128-32. PubMed ID: 8926011
[TBL] [Abstract][Full Text] [Related]
9. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
[TBL] [Abstract][Full Text] [Related]
10. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
Mimura M; Makino H; Kanatsuka A; Yoshida S
Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
[TBL] [Abstract][Full Text] [Related]
11. Changes in Na,K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes.
Garner MH
Metabolism; 1996 Aug; 45(8):927-34. PubMed ID: 8769346
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
Raccah D; Fabreguetts C; Azulay JP; Vague P
Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
[TBL] [Abstract][Full Text] [Related]
13. Association between a novel G94A single nucleotide polymorphism in
Abosheasha MA; Zahran F; Bessa SS; El-Magd MA; Mohamed TM
J Res Med Sci; 2019; 24():62. PubMed ID: 31523248
[TBL] [Abstract][Full Text] [Related]
14. Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+,K+-ATPase activity in diabetes mellitus type I.
Forst T; De La Tour DD; Kunt T; Pfützner A; Goitom K; Pohlmann T; Schneider S; Johansson BL; Wahren J; Löbig M; Engelbach M; Beyer J; Vague P
Clin Sci (Lond); 2000 Mar; 98(3):283-90. PubMed ID: 10677386
[TBL] [Abstract][Full Text] [Related]
15. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus.
Koc B; Erten V; Yilmaz MI; Sonmez A; Kocar IH
Endocrine; 2003 Aug; 21(3):273-8. PubMed ID: 14515013
[TBL] [Abstract][Full Text] [Related]
16. Reduction of erythrocyte (Na(+)-K+)ATPase activity in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Mimura M; Makino H; Kanatsuka A; Asai T; Yoshida S
Horm Metab Res; 1994 Jan; 26(1):33-8. PubMed ID: 8150421
[TBL] [Abstract][Full Text] [Related]
17. Relation of erythrocyte Na+-K+ ATPase activity and cholesterol and oxidative stress in patients with type 2 diabetes mellitus.
Konukoglu D; Kemerli GD; Sabuncu T; Hatemi H
Clin Invest Med; 2003 Dec; 26(6):279-84. PubMed ID: 14690302
[TBL] [Abstract][Full Text] [Related]
18. Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.
Finotti P; Palatini P
Diabetologia; 1986 Sep; 29(9):623-8. PubMed ID: 3025045
[TBL] [Abstract][Full Text] [Related]
19. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients.
Rabini RA; Galassi R; Fumelli P; Dousset N; Solera ML; Valdiguie P; Curatola G; Ferretti G; Taus M; Mazzanti L
Diabetes; 1994 Jul; 43(7):915-9. PubMed ID: 8013757
[TBL] [Abstract][Full Text] [Related]
20. Effects of C-peptide on microvascular blood flow and blood hemorheology.
Forst T; Kunt T
Exp Diabesity Res; 2004; 5(1):51-64. PubMed ID: 15198371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
